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Abstract
National survey data designed to delineate clinician perspectives on the indications to hospitalize 
adolescents for pelvic inflammatory disease indicate that clinicians endorse care consistent with 
the CDC Sexually Transmitted Diseases treatment guidelines, but that there is less agreement on 
the social factors that may impair an adolescent’s ability to self-care in the outpatient setting.
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Pelvic inflammatory disease (PID) is a common reproductive health disorder affecting more 
than 800,000 women each year in the United States.1 Due to biologic and behavioral factors; 
adolescents remain vulnerable to develop the disorder,2–5 which can result in an increased 
risk for known sequelae such as ectopic pregnancy, tubal infertility and chronic pelvic 
pain.6–9 The Centers for Disease Control and Prevention (CDC) no longer recommends that 
all adolescents be hospitalized for PID10 despite findings that indicate adolescents are often 
seen in emergency room settings,11 receive substandard care,12 have difficulty with 
adherence,13 are at risk for recurrent infection,14 and have significant adverse longitudinal 
outcomes such as chronic pelvic pain compared with adult women in national multi-center 
trials.15 Further, there is limited data on early and middle adolescents impacted by PID and 
the potential value of short term hospitalization on the longitudinal outcomes for young 
females presenting for PID care during a unique developmental stage. Fortunately, 
adolescent-serving clinicians have great flexibility in determining the disposition for 
inpatient or outpatient treatment based on their assessment of the patient’s “ability to tolerate 
an outpatient regimen” per the CDC Sexually Transmitted Disease (STD) Treatment 
Guidelines.10 The objective of this study was to delineate clinician perspectives on the 
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indications to hospitalize adolescents for practical application of the CDC guidelines for PID 
management.
Adolescent-serving clinicians were invited through professional listservs to participate in a 
web-based survey to provide opinions on the management of adolescents with PID. After 
piloting the study with local pediatricians and adolescent medicine experts, a letter of 
invitation was sent to members of the Society for Adolescent Health and Medicine and the 
North American Society for Pediatric and Adolescent Gynecology for their review. To be 
included in the survey, participants had to be clinicians who made the final disposition for 
care (physicians, physician assistants, and nurse practitioners). Interested clinicians could 
then click into the study website to review and accept the informed consent parameters and 
subsequently enter the main survey. While t he electronic survey recorded each clinician 
(name and contact information), other survey data were not retained unless they completed 
the entire survey per the online informed consent process. All data were stored in a database 
on a secure institutional network with additional firewall protections. Name and address 
information was collected to provide the $5 remuneration to clinicians for completing the 
survey. Submitted survey data was de-linked from clinician identifiers into a separate file to 
protect the confidentiality of participant responses. Inclusive of the piloting period, the 
survey was open for data collection from May 6, 2009 to March 15, 2010. The Johns 
Hopkins Medicine Institutional Review Board approved the study.
Clinician-participants were asked to first asked to complete a series of utility elicitation 
questions designed to explore health related quality of life and the monetary and time-based 
tradeoffs based on the five health states associated with PID and then to subsequently 
answer questions about hospitalization versus outpatient treatment based on 14 scenarios 
involving a hypothetical 15 year old girl with PID using click/move features of the online 
visual analog scale (VAS).16 This analysis focuses on the responses to seventeen treatment 
scenarios. Prior to offering a scenario, the following prompt was offered to participants:
“Now we are going to ask your opinions on the treatment options for pelvic 
inflammatory disease (PID). Patients who are treated in the hospital usually stay 
for antibiotics by vein (through an IV) for 24–48 hours. After she goes home, she 
will take antibiotics by mouth at home for the remaining 2 weeks. Patients treated 
at home receive antibiotics by mouth for 14 days and are asked to return to the 
doctor’s office within 72 hours for re-evaluation. There are many reasons why a 
doctor may suggest treatment in the hospital instead of being treated at home. 
There are also many reasons why patients may want or need to be treated in the 
hospital or at home. Please indicate how strongly you feel [your patient] should 
be admitted in the following situations.”
The online survey prompts participants to respond to five categories of factors related to 
treatment options (1) Adherence to the CDC STD Treatment Guidelines (severe illness, 
pregnant, not improving as an outpatient), (2) Vulnerability (young age (<15 years), 
developmental delay), (3) Personal barriers (afraid to tell partner, unwilling to take 
prescribed medications), (4) Practical Barriers (lack of transportation, uninsured, homeless) 
and (5) Risk status (recent surgical procedure (e.g. abortion),previous PID, increased risk of 
pregnancy, increased risk of STIs, parent unaware of PID diagnosis). VAS scores ranged 
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from 0 to 10 with 10 indicating the strongest endorsement for hospitalization. Mean scores 
for each scenario were ranked and plotted. Linear regression analyses were used to evaluate 
the role of clinician gender, parenting status, and practice parameters on the observed 
findings based on prior studies demonstrating how personal characteristics and practice 
setting12 influence clinician decisions regarding adolescent reproductive health care and the 
disconnect between adolescent and parent perspectives on PID management.16
Two hundred clinicians opened the web link to review the survey information and 102 
(51%) successfully submitted completed the online survey. Clinicians had a mean age of 
44.8 years SD (10 years). Most were white (81.4%) non-Hispanic (96%), female (83.3%), 
physicians (84%) married (76.5%), parents (70.6%), had pediatric professional training 
(82.4%), and devoted most of their clinical practice to the care of adolescents (70.0%). VAS 
disposition scores varied significantly with the highest scores devoted to those scenarios that 
most closely correlated with the CDC recommendations for PID management (Fig 1). Male 
clinicians had higher VAS scores than female clinicians for post-abortion PID diagnoses in 
linear regression models (β= 0.92, 95% CI: 0.14; 1.17, p=0.02), surgical emergencies 
(β=0.35, 95% CI: 0.17; 0.63, p=0.02), and pregnancy (β= 0.63, 95% CI: 0.04; 1.23, p=0.04). 
The pregnancy model controls for parenting status. Compared to clinician-parents, clinicians 
without children had higher VAS scores for severe illness (β=0.32, 95% CI: 0.17; 0.63, 
p=0.04).
This study indicates that clinicians endorse care that is consistent with the CDC 
recommendations for hospitalization; however, they appear to struggle with the social 
factors that may impair an adolescent’s ability to tolerate an outpatient regimen. Male 
clinicians and clinicians without children were more likely to endorse hospitalization for 
adolescents who were post-abortion/surgery, pregnant required surgery, or had severe 
illness.
The findings from this research must be considered in light of several limitations. The 
generalizability of our findings is limited by the low survey completion rate. This may be 
the result of the study burden. Feedback from survey completers suggests that the survey 
required an unexpected level of mental effort complete the utility elicitation process, which 
involves a complicated time and monetary trade off series, prior to the scenario questions. 
The use of clinical experts may also result in an overestimation for hospitalization 
disposition outcomes; however, a combination of available evidence and clinical expertise 
drives the development of national guidelines. While the findings support the notion that 
clinicians endorse the CDC Guidelines for PID in Adolescents, causality cannot be assumed 
for the observed findings (i.e. that the CDC guidelines may serve as the primary source of 
clinician knowledge and/or decision making) since clinician perceptions of the influence of 
the CDC guidelines on their decision was not directly assessed. Finally, there are no 
measures of actual clinician behavior and/or consideration of multiple clinical factors using 
these standardized patient scenarios.
This study demonstrates that adolescent PID clinician management perspectives mirror 
guidance from the CDC, yet clinical decision-making can be influenced by the clinical 
scenario, clinician gender, and clinician parenting status. While the scores never reached 
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zero for any scenario; the declining values observed for factors that increase risk or make it 
difficult to successfully tolerate an outpatient regimen suggest a lack of agreement about 
managing the disposition for vulnerable adolescent girls. While our results must be used 
with caution because of the difficulty validating estimates based on what people think they 
will do; the observations in this study are consistent with the data demonstrating inconsistent 
care delivery for adolescents with PID across the nation.12 Additional research exploring the 
influence of clinician-assessed psychosocial factors on adolescent PID outcomes, clinical 
scenarios requiring short-term hospitalization, and the role clinical and behavioral 
interventions to support adolescents’ ability to self- manage their care in the outpatient 
setting is warranted. This evidence may enhance the clinical guidance for management of 
PID in adolescents within the CDC STD treatment guidelines and aid in decision-making by 
clinicians caring for adolescents with PID in a variety of settings.
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Short Summary
A national survey demonstrates that while adolescent-serving clinicians endorse the 
indications for PID hospitalization as consistent with Centers for Disease Control and 
Prevention (CDC) guidelines; final disposition is variable and influenced by clinician 
characteristics and patient scenarios.
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Figure 1. 
Provider responses on the disposition-related VAS
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